Medfort Hospitals, a healthcare company with focus on diabetes and eye care treatment services, is planning to invest $40-50 million of growth capital in the next two to three years on its organic and inorganic growth plans.
The company has planned at least two major acquisitions, in the range of $25-30 million in its focus segments, said a senior executive from Medfort.
Medfort Hospitals has plans to raise $40-50 million through various methods including debt and through capital infusion from its existing promoters to support expansion plans, said Gaurav Malhotra, chief executive officer, Medfort Hospitals.
In November, the company raised around Rs 60 crore from TVS Shriram Growth Fund (TSGF) and E Planet Ventures.
“We are looking at both brownfield and greenfield expansion. There would be at least two major acquisitions in the range of $25-30 million. Our vision is to become one of the top three players in eye care and diabetes care business in the next two to three years,” Gaurav Malhotra said.
The company is finalising an acquisition at present and would also look at small scale acquisitions as part of its expansion in the country.
